Xiaohan Ren
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Treatment and Research 4
- Ferroptosis and cancer prognosis 4
-
- Effects and risks of endocrine disrupting chemicals 8
- Toxic Organic Pollutants Impact 4
- Co-authors
- Chao Qin (21 shared papers)Xinglin Chen (16 shared papers)Tongtong Zhang (10 shared papers)Xu Zhang (11 shared papers)Zhongwen Lü (12 shared papers)Shangqian Wang (8 shared papers)Xiyi Wei (10 shared papers)Guangyao Li (8 shared papers)
- Journals
- Aging (4 papers)Scientific Reports (3 papers)Ecotoxicology and Environmental Safety (3 papers)Frontiers in Genetics (3 papers)Frontiers in Endocrinology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaohan Ren
50 papers receiving 1.1k citations
Xiaohan Ren's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 160
- Hepatology 86
- Oncology 198
- Reproductive Medicine 92
- Pulmonary and Respiratory Medicine 246
Countries citing papers authored by Xiaohan Ren
This map shows the geographic impact of Xiaohan Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Ren more than expected).
Fields of papers citing papers by Xiaohan Ren
This network shows the impact of papers produced by Xiaohan Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Ren. The network helps show where Xiaohan Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohan Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia inducible factor-1α drives cancer resistance to cuproptosis Hit paper breakdown → | 2025 | 100 |
| 2 | 2021 | 66 | |
| 3 | 2022 | 57 | |
| 4 | 2021 | 48 | |
| 5 | 2021 | 46 | |
| 6 | 2021 | 43 | |
| 7 | 2020 | 41 | |
| 8 | 2021 | 38 | |
| 9 | 2020 | 37 | |
| 10 | 2021 | 36 | |
| 11 | 2022 | 36 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 33 | |
| 14 | 2021 | 33 | |
| 15 | 2020 | 32 | |
| 16 | 2021 | 32 | |
| 17 | 2019 | 30 | |
| 18 | 2020 | 28 | |
| 19 | 2021 | 28 | |
| 20 | 2020 | 27 |
About Xiaohan Ren
Xiaohan Ren is a scholar working on Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis, Cancer Research, Reproductive Medicine and Oncology, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (8 papers), Renal cell carcinoma treatment (8 papers), Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (4 papers), Ferroptosis and cancer prognosis (4 papers), Toxic Organic Pollutants Impact (4 papers), COVID-19 Clinical Research Studies (3 papers) and Sperm and Testicular Function (3 papers). The work is most often cited by research in Cancer Research (160 citations), Hepatology (86 citations), Oncology (198 citations), Reproductive Medicine (92 citations) and Pulmonary and Respiratory Medicine (246 citations). Xiaohan Ren has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chao Qin, Xinglin Chen, Tongtong Zhang, Xu Zhang, Zhongwen Lü, Shangqian Wang, Xiyi Wei, Guangyao Li, Dong Zhang and Xiang Zhou. Their work appears in journals such as Aging, Scientific Reports, Ecotoxicology and Environmental Safety, Frontiers in Genetics and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.